Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

[Augmentation of antidepressants with unsaturated fatty acids omega-3 in drug-resistant depression].

Krawczyk K, Rybakowski J.

Psychiatr Pol. 2012 Jul-Aug;46(4):585-98. Polish.

PMID:
23214161
2.

Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability.

Ivković M, Damjanović A, Jovanović A, Cvetić T, Jasović-Gasić M.

Psychiatr Danub. 2009 Jun;21(2):187-93.

3.

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.

Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P, Ascher J, Paska W, Earl N, DeVeaugh-Geiss J; Lamictal 605 Study Group.

J Clin Psychiatry. 2003 Sep;64(9):1013-24.

PMID:
14628976
4.

Rapid treatment response of suicidal symptoms to lithium, sleep deprivation, and light therapy (chronotherapeutics) in drug-resistant bipolar depression.

Benedetti F, Riccaboni R, Locatelli C, Poletti S, Dallaspezia S, Colombo C.

J Clin Psychiatry. 2014 Feb;75(2):133-40. doi: 10.4088/JCP.13m08455.

PMID:
24345382
5.

Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study.

Schindler F, Anghelescu IG.

Int Clin Psychopharmacol. 2007 May;22(3):179-82.

PMID:
17414745
6.

Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.

Hantouche EG, Akiskal HS, Lancrenon S, Chatenêt-Duchêne L.

J Affect Disord. 2005 Feb;84(2-3):243-9.

PMID:
15708422
7.

Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.

Alevizos B, Alevizos E, Leonardou A, Zervas I.

Psychiatriki. 2012 Apr-Jun;23(2):143-8.

PMID:
22796912
8.

A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.

Barbee JG, Thompson TR, Jamhour NJ, Stewart JW, Conrad EJ, Reimherr FW, Thompson PM, Shelton RC.

J Clin Psychiatry. 2011 Oct;72(10):1405-12. doi: 10.4088/JCP.09m05355gre.

PMID:
21367355
9.

Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?

Amsterdam JD, Shults J.

J Affect Disord. 2009 May;115(1-2):234-40. doi: 10.1016/j.jad.2008.07.007. Epub 2008 Aug 9.

PMID:
18694599
10.

Long-term lamotrigine plus lithium for bipolar disorder: One year outcome.

Ghaemi SN, Schrauwen E, Klugman J, Berv DA, Shirzadi AA, Pardo TB, Goodwin FK.

J Psychiatr Pract. 2006 Sep;12(5):300-5.

PMID:
16998417
11.

Potentiation of omega-3 fatty acid antidepressant-like effects with low non-antidepressant doses of fluoxetine and mirtazapine.

Laino CH, Fonseca C, Sterin-Speziale N, Slobodianik N, Reinés A.

Eur J Pharmacol. 2010 Dec 1;648(1-3):117-26. doi: 10.1016/j.ejphar.2010.08.047. Epub 2010 Sep 15.

PMID:
20826148
13.

Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.

van der Loos ML, Mulder PG, Hartong EG, Blom MB, Vergouwen AC, de Keyzer HJ, Notten PJ, Luteijn ML, Timmermans MA, Vieta E, Nolen WA; LamLit Study Group.

J Clin Psychiatry. 2009 Feb;70(2):223-31. Epub 2008 Dec 30.

PMID:
19200421
14.

Relationship between plasma concentrations of lamotrigine and its early therapeutic effect of lamotrigine augmentation therapy in treatment-resistant depressive disorder.

Kagawa S, Mihara K, Nakamura A, Nemoto K, Suzuki T, Nagai G, Kondo T.

Ther Drug Monit. 2014 Dec;36(6):730-3. doi: 10.1097/FTD.0000000000000088.

PMID:
24819973
15.
17.

Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: a double-blind, randomized, placebo-controlled trial.

Anand A, Gunn AD, Barkay G, Karne HS, Nurnberger JI, Mathew SJ, Ghosh S.

Bipolar Disord. 2012 Feb;14(1):64-70. doi: 10.1111/j.1399-5618.2011.00971.x.

PMID:
22329473
18.

Lamotrigine augmentation strategy for patients with treatment-resistant depression.

Gutierrez RL, McKercher RM, Galea J, Jamison KL.

CNS Spectr. 2005 Oct;10(10):800-5.

PMID:
16400242
19.

Gabapentin augmentation therapy in bipolar depression.

Wang PW, Santosa C, Schumacher M, Winsberg ME, Strong C, Ketter TA.

Bipolar Disord. 2002 Oct;4(5):296-301.

PMID:
12479661
20.

Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.

Amsterdam JD, Shults J.

J Clin Psychopharmacol. 2008 Apr;28(2):171-81. doi: 10.1097/JCP.0b013e318166c4e6.

PMID:
18344727

Supplemental Content

Support Center